ArticleMolecular therapy. Nucleic acids2022

Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer.

Cun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.